J Bone Oncol. 2017 Nov 26;11:10-16. doi: 10.1016/j.jbo.2017.11.003. eCollection 2018 Jun.
Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst.
Journal of bone oncology
Jun-Qiang Yin, Yi-Wei Fu, Xian-Biao Xie, Xiao-Yu Cheng, Xiao-Yu Yang, Wei-Hai Liu, Jian Tu, Zhen-Hua Gao, Jing-Nan Shen
Affiliations
Affiliations
- Department of Orthopedic Oncology, First Affiliated Hospital of Sun Yat-Sen University, 58 Second Zhongshan Road, Guangzhou, Guangdong, China.
- Zhongshan School of Medicine, Sun Yat-Sen University, 74 Second Zhongshan Road, Guangzhou, Guangdong, China.
- Department of Radiology, First Affiliated Hospital of Sun Yat-Sen University, 58 Second Zhongshan Road, Guangzhou, Guangdong, China.
PMID: 29892520
PMCID: PMC5993956 DOI: 10.1016/j.jbo.2017.11.003
Abstract
BACKGROUND AND PURPOSE: Telangiectatic osteosarcoma (TOS), a rare variant of osteosarcoma, may be easily misdiagnosed as aneurysmal bone cyst (ABC). The aims of this study were to investigate the diagnostic and prognostic factors of TOS by reviewing our experience with TOS and to develop a diagnostic model that may distinguish TOS from ABC.
MATERIALS AND METHODS: We identified 51 cases of TOS treated at the First Affiliated Hospital of Sun Yat-Sen University from March 2001 to January 2016 and reviewed their records, imaging information and pathological studies. A diagnostic model was developed to differentiate TOS and ABC by Bayes discriminant analysis and was evaluated. The log-rank test was used to analyze the prognostic factors of TOS and to compare the outcome differences between TOS and other high-grade osteosarcoma subtypes.
RESULTS: The multi-disciplinary diagnostic method employed that combined clinical, imaging, and pathological studies enhanced the diagnostic accuracy. Age 18 years or younger and pathologic fracture were more common among the TOS patients than among the ABC patients
CONCLUSIONS: The multi-disciplinary diagnostic method and diagnostic model based on predictive factors,
Keywords: ABC, Aneurysmal bone cyst; ALP, Alkaline phosphatase; Aneurysmal bone cyst; Diagnostic model; Discriminant analysis; EFS, Event-free survival; LDH, Lactate dehydrogenase; MR, Magnetic resonance; MTX, Methotrexate; OS, Osteosarcoma; Prognostic factor; SD, Standard deviations; TOS, Telangiectatic osteosarcoma; Telangiectatic osteosarcoma; WBC, White blood cell
References
- Onco Targets Ther. 2013 May 28;6:593-602 - PubMed
- Cancer. 1974 Oct;34(4):1150-8 - PubMed
- Radiographics. 2010 Oct;30(6):1653-72 - PubMed
- Clin Orthop Relat Res. 1996 Mar;(324):227-32 - PubMed
- J Cancer Res Clin Oncol. 2016 Oct;142(10 ):2197-207 - PubMed
- Clin Orthop Relat Res. 1991 Sep;(270):135-9 - PubMed
- Cancer Imaging. 2013 Dec 11;13(4):520-6 - PubMed
- J Clin Oncol. 2005 Dec 1;23(34):8845-52 - PubMed
- Eur J Surg Oncol. 2012 Dec;38(12):1171-7 - PubMed
- Clin Orthop Relat Res. 1986 Jun;(207):164-73 - PubMed
- Cancer Treat Res. 2014;162:65-92 - PubMed
- Cancer. 1982 Apr 15;49(8):1679-89 - PubMed
- Oncotarget. 2015 Nov 10;6(35):38348-59 - PubMed
- J Orthop Surg (Hong Kong). 2013 Apr;21(1):96-9 - PubMed
- Acta Orthop Scand. 2001 Apr;72(2):167-72 - PubMed
- Cancer. 1976 Dec;38(6):2538-47 - PubMed
- Radiology. 2003 Nov;229(2):545-53 - PubMed
- J Neurosurg Spine. 2012 Apr;16(4):373-8 - PubMed
- World J Surg Oncol. 2012 Feb 15;10:37 - PubMed
- Osteoporos Int. 2000;11(4):281-94 - PubMed
- Arch Pathol Lab Med. 2012 May;136(5):572-6 - PubMed
- Cancer. 2007 Apr 15;109(8):1627-37 - PubMed
Publication Types